We are very pleased to be part of AmCham and are looking forward to driving innovation forward in Latvia.
Mikko Fernström, General Manager, Biogen Latvia
AmCham released two new positions focusing on the development of advanced technologies – AI and Precision medicine – in Latvia. Our positions outline the need for a supportive and collaborative ecosystem to implement these cutting-edge technologies. By investing in the infrastructure and knowledge in these areas, Latvia has the potential to transform itself into a hub of excellence, attracting global partnerships and fostering innovation that benefits society at large.
The position of Development of AI and Digital Affairs and Unlocking AI Opportunities underscores the importance of digital transformation and AI in enhancing productivity and innovation. It emphasizes the need for collaboration to tackle AI adoption and regulation challenges, aiming to strengthen Latvia’s position in the global digital economy. The paper advocates for developing digital skills, responsible AI use, and a supportive regulatory framework aligned with EU policies, while avoiding over-regulation.
The position on The Development of Precision Medicine in Latvia underlines the value precision medicine has for patients and the broader economy. It offers immense opportunities for economic and healthcare innovations in the fields of diagnostics, treatments, and data processing. The document calls to promote closer cooperation among stakeholders and ensure the targeted development of precision medicine in Latvia.
As an organization representing leaders across various industries, AmCham is committed to working closely with all stakeholders to enhance Latvia’s economic security by attracting investment and increasing national competitiveness with a focus on digital transition and human capital.
We re-affirm our commitment to the values that AmCham stands for and that we share.
Kārlis Danēvičs, Board member, Head of Credits and Risk at SEB Banka